Lexicon Pharmaceuticals, Inc. SEC filings LXRX
Lexicon Pharmaceuticals, Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Jan 8, 2010. Its latest annual report, Form ARS, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 5, 2026 | — |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| EFFECT | Filing | Aug 14, 2026 | — |
| S-3 | Shelf registration | Aug 6, 2026 | — |
| S-8 | Employee stock plan registration | Aug 6, 2026 | — |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 6, 2026 | — |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | May 8, 2026 | Apr 30, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 8, 2026 | — |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
May 6, 2026 | May 4, 2026 |
| 4 | Insider transaction | May 4, 2026 | May 1, 2026 |
| 4 | Insider transaction | May 4, 2026 | May 1, 2026 |
| 4 | Insider transaction | May 4, 2026 | May 1, 2026 |
| 4 | Insider transaction | May 4, 2026 | May 1, 2026 |
| 4 | Insider transaction | May 4, 2026 | May 1, 2026 |
| 4 | Insider transaction | May 4, 2026 | May 1, 2026 |
| 4 | Insider transaction | May 4, 2026 | May 1, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Shareholder vote results
|
Apr 30, 2026 | Apr 30, 2026 |
| ARS | Annual report to shareholders | Mar 16, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Mar 16, 2026 | — |
| DEF 14A | Proxy statement | Mar 16, 2026 | Mar 16, 2026 |
| 10-K | Annual report | Mar 5, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 5, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 28, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 28, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 28, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 28, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 28, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 28, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 28, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 28, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 25, 2026 |
| 4 | Insider transaction | Feb 25, 2026 | Feb 23, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 19, 2026 |
| 4 | Insider transaction | Feb 19, 2026 | Feb 17, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 13, 2026 |
| PRE 14A | Preliminary proxy statement | Feb 17, 2026 | Feb 17, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| D | Filing | Feb 17, 2026 | — |
| 3 | Initial insider ownership | Feb 12, 2026 | Feb 2, 2026 |
| FWP | Free writing prospectus | Feb 6, 2026 | — |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 2, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Feb 2, 2026 | Jan 29, 2026 |
| 424B5 | Prospectus supplement | Feb 2, 2026 | — |
| FWP | Free writing prospectus | Jan 30, 2026 | — |
| FWP | Free writing prospectus | Jan 30, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 29, 2026 | Jan 29, 2026 |
| 424B5 | Prospectus supplement | Jan 29, 2026 | — |
| 8-K |
Current report
Other events
|
Nov 10, 2025 | Nov 6, 2025 |
| 424B5 | Prospectus supplement | Nov 6, 2025 | — |
| 8-K |
Current report
Other events
|
Nov 6, 2025 | Nov 6, 2025 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| S-8 | Employee stock plan registration | Aug 6, 2025 | — |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Other events
|
Jul 28, 2025 | Jul 23, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 8, 2025 | — |
| 8-K |
Current report
Other events
|
Jul 3, 2025 | Jul 3, 2025 |
| 3 | Initial insider ownership | Jun 9, 2025 | Jun 1, 2025 |
| 3 | Initial insider ownership | Jun 6, 2025 | Jun 1, 2025 |
| 4 | Insider transaction | Jun 3, 2025 | Jun 3, 2025 |
| 4 | Insider transaction | Jun 3, 2025 | Jun 3, 2025 |
| 4 | Insider transaction | Jun 3, 2025 | Jun 3, 2025 |
| 4 | Insider transaction | Jun 3, 2025 | Jun 3, 2025 |
| 4 | Insider transaction | Jun 3, 2025 | Jun 3, 2025 |
| 4 | Insider transaction | Jun 3, 2025 | Jun 3, 2025 |
| 4 | Insider transaction | Jun 3, 2025 | Jun 3, 2025 |
| 8-K |
Current report
Material agreement, Shareholder vote results
|
Jun 3, 2025 | Jun 2, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | May 13, 2025 | May 13, 2025 |
| 4 | Insider transaction | May 13, 2025 | May 13, 2025 |
| 4 | Insider transaction | May 13, 2025 | May 13, 2025 |
| 4 | Insider transaction | May 13, 2025 | May 13, 2025 |
| 4 | Insider transaction | May 13, 2025 | May 13, 2025 |
| 4 | Insider transaction | May 13, 2025 | May 13, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 12, 2025 | — |
| ARS | Annual report to shareholders | Apr 22, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 22, 2025 | — |
| DEF 14A | Proxy statement | Apr 22, 2025 | Apr 22, 2025 |
| 8-K |
Current report
Material agreement
|
Mar 28, 2025 | Mar 27, 2025 |
| PRE 14A | Preliminary proxy statement | Mar 25, 2025 | Mar 20, 2025 |
| 10-K | Annual report | Mar 7, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2025 | Mar 6, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 28, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 28, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 28, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 28, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 28, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 28, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 8-K |
Current report
Listing notice
|
Jan 7, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Jan 2, 2025 | Jan 2, 2025 |
| 3 | Initial insider ownership | Jan 2, 2025 | Jan 2, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 2, 2025 | Jan 2, 2025 |
| 3 | Initial insider ownership | Dec 16, 2024 | Dec 5, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Dec 9, 2024 | — |
| 4 | Insider transaction | Dec 2, 2024 | Dec 2, 2024 |
| 3 | Initial insider ownership | Dec 2, 2024 | Dec 2, 2024 |
| 8-K |
Current report
Exit or restructuring costs
|
Nov 22, 2024 | Nov 22, 2024 |
| 8-K |
Current report
Officer or director change
|
Nov 20, 2024 | Nov 19, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| 8-K |
Current report
Material agreement
|
Oct 16, 2024 | Oct 16, 2024 |
| 3 | Initial insider ownership | Oct 7, 2024 | Oct 2, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 16, 2024 | Sep 13, 2024 |
| EFFECT | Filing | Aug 15, 2024 | — |
| 144 | Notice of proposed sale | Aug 15, 2024 | — |
| 4 | Insider transaction | Aug 12, 2024 | Aug 12, 2024 |
| 3 | Initial insider ownership | Aug 12, 2024 | Aug 12, 2024 |
| CORRESP | Letter to the SEC | Aug 9, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 8, 2024 | — |
| S-3 | Shelf registration | Aug 2, 2024 | — |
| 10-Q | Quarterly report | Aug 2, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2024 | Aug 1, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Jul 29, 2024 | — |
| 3 | Initial insider ownership | Jul 29, 2024 | Jul 25, 2024 |
| SC 13G | Ownership over 5% (passive) | Jul 10, 2024 | — |
| 4 | Insider transaction | Jul 8, 2024 | Jul 8, 2024 |
| 4 | Insider transaction | Jul 8, 2024 | Jul 8, 2024 |
| 3 | Initial insider ownership | Jul 8, 2024 | Jul 8, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 8, 2024 | Jul 3, 2024 |
| 8-K |
Current report
Material agreement
|
Jul 1, 2024 | Jun 28, 2024 |
| EFFECT | Filing | May 15, 2024 | — |
| 4 | Insider transaction | May 14, 2024 | May 10, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | May 14, 2024 | — |
| CORRESP | Letter to the SEC | May 13, 2024 | — |
| 4 | Insider transaction | May 13, 2024 | May 13, 2024 |
| 4 | Insider transaction | May 13, 2024 | May 13, 2024 |
| 4 | Insider transaction | May 13, 2024 | May 13, 2024 |
| 4 | Insider transaction | May 13, 2024 | May 13, 2024 |
| 4 | Insider transaction | May 13, 2024 | May 13, 2024 |
| 4 | Insider transaction | May 13, 2024 | May 13, 2024 |
| 4 | Insider transaction | May 13, 2024 | May 13, 2024 |
| S-3/A | Filing | May 10, 2024 | — |
| 8-K |
Current report
Unregistered share sale, Bylaw or fiscal year change, Shareholder vote results
|
May 10, 2024 | May 10, 2024 |
| 10-Q | Quarterly report | May 2, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 2, 2024 | May 2, 2024 |
| 4 | Insider transaction | Apr 29, 2024 | Apr 28, 2024 |
| 4 | Insider transaction | Apr 29, 2024 | Apr 28, 2024 |
| 4 | Insider transaction | Apr 29, 2024 | Apr 28, 2024 |
| 4 | Insider transaction | Apr 29, 2024 | Apr 28, 2024 |
| 4 | Insider transaction | Apr 29, 2024 | Apr 28, 2024 |
| 4 | Insider transaction | Apr 29, 2024 | Apr 28, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 29, 2024 | Apr 29, 2024 |
| UPLOAD | Letter from the SEC | Mar 29, 2024 | — |
| ARS | Annual report to shareholders | Mar 26, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Mar 26, 2024 | — |
| DEF 14A | Proxy statement | Mar 26, 2024 | Mar 25, 2024 |
| S-3 | Shelf registration | Mar 25, 2024 | — |
| 10-K | Annual report | Mar 25, 2024 | Dec 31, 2023 |
| 4 | Insider transaction | Mar 13, 2024 | Mar 13, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Mar 13, 2024 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Mar 12, 2024 | Mar 12, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 11, 2024 | Mar 11, 2024 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Bylaw or fiscal year change, Regulation FD disclosure
|
Mar 11, 2024 | Mar 6, 2024 |
| 4 | Insider transaction | Feb 29, 2024 | Feb 28, 2024 |
| 4 | Insider transaction | Feb 29, 2024 | Feb 28, 2024 |
| 4 | Insider transaction | Feb 29, 2024 | Feb 28, 2024 |
| 4 | Insider transaction | Feb 29, 2024 | Feb 28, 2024 |
| 4 | Insider transaction | Feb 29, 2024 | Feb 28, 2024 |
| 4 | Insider transaction | Feb 29, 2024 | Feb 28, 2024 |
| 4 | Insider transaction | Feb 29, 2024 | Feb 28, 2024 |
| 4 | Insider transaction | Feb 29, 2024 | Feb 28, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| 4 | Insider transaction | Feb 12, 2024 | Feb 8, 2024 |
| 4 | Insider transaction | Feb 12, 2024 | Feb 8, 2024 |
| 4 | Insider transaction | Feb 12, 2024 | Feb 8, 2024 |
| 4 | Insider transaction | Feb 12, 2024 | Feb 8, 2024 |
| 4 | Insider transaction | Feb 12, 2024 | Feb 8, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LXRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- The Woodlands, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1062822
- Former names
- LEXICON PHARMACEUTICALS, INC./DE (until Dec 5, 2014); LEXICON GENETICS INC/TX (until Apr 2, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.